Vaccination trials against vibriosis in shrimp: A review

Marine actinomycetes Nocardiopsis alba MCCB 110 has immunomodulatory property in the tiger shrimp Penaeus monodon.

In vitro evaluation of antibiofilm activity of crude extracts from macroalgae against pathogens relevant in aquaculture

Infectious diseases in shrimp are one of the significant constraints in shrimp aquaculture across the globe. The alarming increase of antibiotic resistance in bacteria has rendered antibiotic therapy a controversial subject today. Therefore, the practice of antibiotic therapy in aquaculture needs to be dissuaded and appropriate alternatives have to be found out. For the past few decades, the field of nanotechnology and biotechnology has proposed novel and effective solutions involving the use of nanoparticles, biofilm-based vaccines, algal extracts, phytobiotics, probiotics, prebiotics, and synbiotics to combat infectious diseases. Algal extracts, phytobiotics, probiotics, prebiotics, and synbiotics are compounds of biological origin due to which they are safe to use in aquaculture settings. With the advent of green and bio-nanotechnology, nanomaterials are also becoming a safer alternative to antibiotic therapy. Vaccines developed from antigenic components of bacterial biofilms are more promising than regular vaccines synthesized from antigens of planktonic forms. Some of these methods have extended applications in shrimp aquaculture in the form of immunomodulants, diagnostic tools, drug and vaccine carriers. The hazards of chemotherapy in shrimp aquaculture can be overcome by replacing antibiotics and other chemical agents with these new approaches. Adopting these strategies makes aquaculture-based food more organic, consumer-friendly and helps in establishing sustainable aquaculture. This review reveals the ill effects of antibiotic therapy in shrimp aquaculture and casts light on the advantages and the research gaps in these strategies that need to be addressed.

Shrimp disease management for sustainable aquaculture: innovations from nanotechnology and biotechnology

https://krishi.icar.gov.in/jspui/bitstream/123456789/34810/1/Vibrio%20harveyi%20biofilm%20as%20immunostimulant%20candidate%20for%20high-health%20pacific%20white%20shrimp%2c%20Penaeus%20vannamei%20farming%20_%20Elsevier%20Enhanced%20Reader.pdf

Vibrio harveyi biofilm as immunostimulant candidate for high-health pacific white shrimp, Penaeus vannamei farming.

Evaluation of Therapeutic Efficiency of Stylicin against Vibrio parahaemolyticus Infection in Shrimp Penaeus vannamei through Comparative Proteomic Approach.

COPYRIGHT © 2023 Thangaraj, Nathamuni, Katneni, Jangam, Avunje, Thulasi, Grover, Angel and Shekhar. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. TYPE Data Report PUBLISHED 05 May 2023 DOI 10.3389/fmars.2023.1120004

/pdf/microbial-communities-associated-with-zoea-2-syndrome-and-q6ouvvll.pdf

Sathish Kumar Thangaraj

Papers

Vibrio harveyi biofilm as immunostimulant candidate for high-health pacific white shrimp, Penaeus vannamei farming.

Evaluation of Therapeutic Efficiency of Stylicin against Vibrio parahaemolyticus Infection in Shrimp Penaeus vannamei through Comparative Proteomic Approach.

Microbial communities associated with Zoea-2 syndrome and White feces syndrome in P. vannamei farming